Literature DB >> 31620850

Whole-body magnetic resonance imaging of pediatric cancer predisposition syndromes: special considerations, challenges and perspective.

Sandra Saade-Lemus1, Andrew J Degnan2, Michael R Acord2, Abhay S Srinivasan2, Janet R Reid2, Sabah E Servaes2, Lisa J States2, Sudha A Anupindi2.   

Abstract

Cancer predisposition syndromes increase the incidence of tumors during childhood and are associated with significant morbidity and mortality. Imaging is paramount for ensuring early detection of neoplasms, impacting therapeutic interventions and potentially improving outcome. While conventional imaging techniques involve considerable exposure to ionizing radiation, whole-body MRI is a radiation-free modality that allows continuous imaging of the entire body and has increasingly gained relevance in the surveillance, diagnosis, staging and monitoring of pediatric patients with cancer predisposition syndromes. Nevertheless, widespread implementation of whole-body MRI faces several challenges as a screening tool. Some of these challenges include developing clinical indications, variability in protocol specifications, image interpretation as well as coding and billing practices. These factors impact disease management, patient and family experience and research collaborations. In this discussion we review the aforementioned special considerations and the potential direction that might help overcome these challenges and promote more widespread use of whole-body MRI in children with cancer predisposition syndromes.

Entities:  

Keywords:  Cancer predisposition syndromes; Children; Li–Fraumeni syndrome; Magnetic resonance imaging; Solid tumor; Whole-body

Year:  2019        PMID: 31620850     DOI: 10.1007/s00247-019-04431-3

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  36 in total

1.  Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.

Authors:  Mandy L Ballinger; Ana Best; Phuong L Mai; Payal P Khincha; Jennifer T Loud; June A Peters; Maria Isabel Achatz; Rubens Chojniak; Alexandre Balieiro da Costa; Karina Miranda Santiago; Judy Garber; Allison F O'Neill; Rosalind A Eeles; D Gareth Evans; Eveline Bleiker; Gabe S Sonke; Marielle Ruijs; Claudette Loo; Joshua Schiffman; Anne Naumer; Wendy Kohlmann; Louise C Strong; Jasmina Bojadzieva; David Malkin; Surya P Rednam; Elena M Stoffel; Erika Koeppe; Jeffrey N Weitzel; Thomas P Slavin; Bita Nehoray; Mark Robson; Michael Walsh; Lorenzo Manelli; Anita Villani; David M Thomas; Sharon A Savage
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

2.  Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study.

Authors:  Danielle Novetsky Friedman; Eric Lis; Charles A Sklar; Kevin C Oeffinger; Marina Reppucci; Megan Harlan Fleischut; Jasmine H Francis; Brian Marr; David H Abramson; Ira J Dunkel
Journal:  Pediatr Blood Cancer       Date:  2013-11-01       Impact factor: 3.167

Review 3.  Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI.

Authors:  Mary-Louise C Greer; Stephan D Voss; Lisa J States
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531

Review 4.  Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.

Authors:  D Gareth R Evans; Hector Salvador; Vivian Y Chang; Ayelet Erez; Stephan D Voss; Harriet Druker; Hamish S Scott; Uri Tabori
Journal:  Clin Cancer Res       Date:  2017-06-15       Impact factor: 12.531

5.  The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking Glass.

Authors:  David Malkin; Kim E Nichols; Joshua D Schiffman; Sharon E Plon; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-11-01       Impact factor: 12.531

Review 6.  The role of whole-body MRI in pediatric oncology.

Authors:  Karen L Atkin; Michael R Ditchfield
Journal:  J Pediatr Hematol Oncol       Date:  2014-07       Impact factor: 1.289

Review 7.  Imaging of cancer predisposition syndromes in children.

Authors:  Johanna Monsalve; Jeevesh Kapur; David Malkin; Paul S Babyn
Journal:  Radiographics       Date:  2011 Jan-Feb       Impact factor: 5.333

Review 8.  Whole-body MR imaging in children: principles, technique, current applications, and future directions.

Authors:  Govind B Chavhan; Paul S Babyn
Journal:  Radiographics       Date:  2011-10       Impact factor: 5.333

9.  Current utilization and procedural practices in pediatric whole-body MRI.

Authors:  Gary R Schooler; Joseph T Davis; Heike E Daldrup-Link; Donald P Frush
Journal:  Pediatr Radiol       Date:  2018-05-02

Review 10.  Whole-body MRI in paediatric oncology.

Authors:  Rutger A J Nievelstein; Annemieke S Littooij
Journal:  Radiol Med       Date:  2015-12-02       Impact factor: 3.469

View more
  5 in total

1.  Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes.

Authors:  Sietse M Aukema; Selina Glaser; Mari F C M van den Hout; Sonja Dahlum; Marinus J Blok; Morten Hillmer; Julia Kolarova; Raf Sciot; Dina A Schott; Reiner Siebert; Constance T R M Stumpel
Journal:  Fam Cancer       Date:  2022-07-19       Impact factor: 2.446

Review 2.  Cancer predisposition in pediatric neuro-oncology-practical approaches and ethical considerations.

Authors:  Steffen Hirsch; Nicola Dikow; Stefan M Pfister; Kristian W Pajtler
Journal:  Neurooncol Pract       Date:  2021-05-28

Review 3.  [Imaging of tumor predisposition syndromes].

Authors:  K Glutig; A Pfeil; D M Renz
Journal:  Radiologe       Date:  2021-06-25       Impact factor: 0.635

Review 4.  Screening of cancer predisposition syndromes.

Authors:  Haifa Al-Sarhani; Ravi V Gottumukkala; Angelo Don S Grasparil; Eric L Tung; Michael S Gee; Mary-Louise C Greer
Journal:  Pediatr Radiol       Date:  2021-04-01

5.  Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.

Authors:  M C Frühwald; K Nemes; H Boztug; M C A Cornips; D G Evans; R Farah; S Glentis; M Jorgensen; K Katsibardi; S Hirsch; K Jahnukainen; I Kventsel; K Kerl; C P Kratz; K W Pajtler; U Kordes; V Ridola; E Stutz; F Bourdeaut
Journal:  Fam Cancer       Date:  2021-02-03       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.